Exact Mass: 258.99729940000003
Exact Mass Matches: 258.99729940000003
Found 291 metabolites which its exact mass value is equals to given mass value 258.99729940000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
Glucosamine 6-phosphate (CAS: 3616-42-0) is normally produced in endothelial cells via de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. Glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals.It is a member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus (PMID:11270676, 11842094). Glucosamine 6-phosphate is normally produced in endothelial cells via the de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals. A member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus. (PMID 11270676, 11842094) [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID G021; [MS2] KO008968 KEIO_ID G021
Glucosamine-1P
C6H14NO8P (259.04570140000004)
Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). [HMDB] Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). KEIO_ID G065
N-Sulfo-D-glucosamine
N-Sulfo-D-glucosamine is a structurally altered form of N-acetyl-D-glucosamine (a polysaccharide found in animal tissues) by heparan sulfate N-deacetylase /N-sulfotransferase enzymes. No human references found [HMDB]
scyllo-Inosamine 4-phosphate
C6H14NO8P (259.04570140000004)
Kanosamine 6-phosphate
C6H14NO8P (259.04570140000004)
Aminofructose 6-phosphate
C6H14NO8P (259.04570140000004)
This compound belongs to the family of Pentose Phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups.
Vinclozolin M2
C11H11Cl2NO2 (259.01668060000003)
3-Bromotyrosine
3-Bromotyrosine(BY) is generated from the halogenation of tyrosine residues in plasma proteins via the enzyme Eosinophil peroxidase. The presence of free bromotyrosine in blood or urine is the result of enzymatic degradation of these brominated proteins. A significantly higher concentration of BY was observed in the urine from asthmatic patients than in that from healthy control subjects (PMID: 15196282). Bromotyrosine may be useful for monitoring the activation of eosinophils in asthmatic patients. 3-Bromotyrosine(BY) is generated from the halogenation of tyrosine residues in plasma proteins via the enzyme Eosinophil peroxidase. A significantly higher concentration of BY was observed in the urine from asthmatic patients than in that from healthy control subjects (PMID: 15196282). [HMDB]
D-Galactosamine 6-phosphate
C6H14NO8P (259.04570140000004)
A galactosamine phosphate that is D-galactosamine substituted at position 1 by a monophosphate group.
Glucosamine 6-sulfate
Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239) [HMDB] Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239).
D-Glucosamine-6-phosphate
C6H14NO8P (259.04570140000004)
Glycerophosphoserine
C6H14NO8P (259.04570140000004)
1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate
1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate is soluble (in water) and a moderately acidic compound (based on its pKa). 1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate can be found in a number of food items such as butternut, pigeon pea, saskatoon berry, and ostrich fern, which makes 1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate a potential biomarker for the consumption of these food products.
methyl N-[(3-chlorophenyl)carbamothioyl]carbamimidothioate
2,6-di[(methoxythio)carbonyl]pyridine
C9H9NO4S2 (258.99729940000003)
D-Glucosamine-6-phosphate sodium salt
C6H14NO8P (259.04570140000004)
4-Bromo-2,5-dimethoxyphenethylamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE
1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE
(4-(5-CHLOROTHIOPHEN-2-YL)PHENYL)METHANAMINE HYDROCHLORIDE
2-Dichloromethyl-7-Methyl-3-nitro-imidazo[1,2-a]pyridine
2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine
1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol
C11H11Cl2NO2 (259.01668060000003)
2-Butenoic acid,4-[(2,5-dichlorophenyl)amino]-4-oxo-, (Z)- (9CI)
4-(2-AMINO-2-CARBOXYETHYL)BENZO[C]-2,1,3-THIADIAZOLE, HYDROCHLORIDE
C9H10ClN3O2S (259.01822300000003)
2-Pentanamine, 1-bromo-4-methyl-, hydrobromide, (S)-
2-Pentanamine, 1-bromo-4-methyl-, hydrobromide, (R)-
ETHYL 5-BROMO-1-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLATE
1-ACETYLINDOLINE-5-SULFONYL CHLORIDE
C10H10ClNO3S (259.00699000000003)
4-CHLORO-2-(2-PYRIDINYL)-6-(TRIFLUOROMETHYL)-PYRIMIDINE
5-(2,4-DICHLORO-BENZYL)-[1,3,4]THIADIAZOL-2-YLAMINE
3,5-bis(methylsulfonyl)benzonitrile
C9H9NO4S2 (258.99729940000003)
6-chloro-3-(trifluoromethyl)pyridine-2-carboximidamide,hydrochloride
C7H6Cl2F3N3 (258.98908520000003)
6,7-DIHYDROXY-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE
3-chloro-5-(trifluoromethyl)pyridine-2-carboximidamide,hydrochloride
C7H6Cl2F3N3 (258.98908520000003)
2-dimethoxyphosphinothioylsulfanyl-N-(methoxymethyl)acetamide
(+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HBR
2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
2-(2-BROMO-4,5-DIMETHOXYPHENYL)ETHANAMINE HYDROCHLORIDE
3-[2-fluoro-4-(trifluoromethyl)phenyl]pyrrole-2,5-dione
C11H5F4NO2 (259.02563979999996)
methyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate
5-[(2-methyl-1-benzofuran-6-yl)methylidene]-1,3-thiazolidine-2,4-dione
4-(2-oxopyrrolidin-1-yl)benzenesulfonyl chloride
C10H10ClNO3S (259.00699000000003)
2,3-Naphthalenediol,6-amino-5,6,7,8-tetrahydro-, hydrobromide (1:1)
4-CHLORO-4-HYDROXY-3-METHOXY-[1,1-BIPHENYL]-3-CARBONITRILE
2-BROMO-4-CHLORO-1,6-DIMETHYL-1H-IMIDAZO[4,5-C]PYRIDINE
4-Phenyl-5-(2-thienyl)-4H-1,2,4-triazol-3-ylhydrosulfide
2-Chloro-4-(trifluoromethyl)benzenesulfonamide
C7H5ClF3NO2S (258.96816160000003)
6-fluoro-4-(trifluoromethyl)quinoline-2-carboxylic acid
C11H5F4NO2 (259.02563979999996)
3-AMINO-3-(3-BROMO-4-HYDROXY-PHENYL)-PROPIONIC ACID
3-(2-OXOPYRROLIDIN-1-YL)BENZENE-1-SULFONYL CHLORIDE
C10H10ClNO3S (259.00699000000003)
4-oxo-4-[3-(trifluoromethyl)anilino]but-2-enoic acid
2-CHLORO-5-TRIFLUOROMETHYL-BENZENESULFONAMIDE
C7H5ClF3NO2S (258.96816160000003)
4-Chloro-2-(3-pyridinyl)-6-(trifluoromethyl)pyrimidine
3a-(Trifluoromethyl)-3,3a-dihydrobenzo[d]pyrrolo[2,1-b]thiazol-1(2H)-one
2-chloro-5-(trifluoromethylsulfonyl)aniline
C7H5ClF3NO2S (258.96816160000003)
(Z)-2-(Methoxycarbonylmethoxyimino)-2-(2-aminothiazol-4-yl)acetic acid
C8H9N3O5S (259.02629040000005)
2-amino-5-methyl-4-(4-nitrophenyl)thiophene-3-carbonitrile
5-Methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2-(AMINOMETHYL)-5-(4-CHLOROPHENYL)THIOPHENE HYDROCHLORIDE
2-(2,6-DICHLOROPHENOXY)-3-(DIMETHYLAMINO)ACRYLALDEHYDE
C11H11Cl2NO2 (259.01668060000003)
ETHYL 2-CHLORO-4-(TRIFLUOROMETHYL)-1,3-THIAZOLE-5-CARBOXYLATE
C7H5ClF3NO2S (258.96816160000003)
N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide
C9H14BrN3O (259.03201740000003)
Methyl 6-methoxyformamido-4-chloropyridin-2-ylcarbamate
7-AMINO-1,8-NAPHTHYRIDIN-2(1H)-ONE SULFATE
C8H9N3O5S (259.02629040000005)
2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
2-BROMO-5,5-DIMETHYL-5,6-DIHYDROBENZO[D]THIAZOL-7(4H)-ONE
2-Amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide
2,6-dichloro-3-(2-chloroethyl)quinoline
C11H8Cl3N (258.97222980000004)
2,7-dichloro-3-(2-chloroethyl)quinoline
C11H8Cl3N (258.97222980000004)
8-chloro-1-oxido-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-1-ium-11-one
2-oxo-1,3,4,5-tetrahydro-1-benzazepine-7-sulfonyl chloride
C10H10ClNO3S (259.00699000000003)
2-chloro-6-morpholin-4-yl-5-nitropyrimidin-4-amine
C8H10ClN5O3 (259.04721400000005)
2-Butenoic acid,4-[(3,4-dichlorophenyl)amino]-4-oxo-
5-(2,4-DICHLOROPHENYL)-4-METHYL-1,2,4-TRIAZOLE-3-THIOL
4-chloro-2-(1-methylimidazol-2-yl)sulfanyl-1,3-thiazole-5-carbaldehyde
ETHYL 5,7-DICHLOROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLATE
5-(2-pyridyl)thiophene-2-sulfonyl chloride
C9H6ClNO2S2 (258.95284860000004)
2-Benzimidazolecarbamic acid, 5,6-dichloro-, methyl ester
methyl 5-chloroindeno[1,2-b]pyridine-5-carboxylate
N-[(4S,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide
3-Bromo-L-tyrosine
A bromoamino acid comprising an L-tyrosine core with a bromo- substituent ortho to the hydroxy group on the benzene ring.
(3S,4R)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid
C11H11Cl2NO2 (259.01668060000003)
(3S,4R)-4-(2,3-dichlorophenyl)pyrrolidine-3-carboxylic acid
C11H11Cl2NO2 (259.01668060000003)
[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methanol
N-((4R,6S)-6-METHYL-7,7-DIOXIDO-5,6-DIHYDRO-4H-THIENO[2,3-B]THIOPYRAN-4-YL)ACETAMIDE
(5-Amino-2,3,4-trihydroxy-6-oxohexyl) dihydrogen phosphate
C6H14NO8P (259.04570140000004)
6-Fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one
3-Amino-4-chloro-N-(2-cyanoethyl)benzenesulfonamide
C9H10ClN3O2S (259.01822300000003)
5-(1-naphthalenylamino)-3H-1,3,4-thiadiazole-2-thione
Sn-glycero-3-phosphoserine
C6H14NO8P (259.04570140000004)
A glycerol 1-phosphoserine in which the glycero portion has R-configuration.
[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl sulfate
C6H11O9S- (259.01237760000004)
Glucosamine 6-Phosphate (closed ring, complete stereochemistry)
C6H14NO8P (259.04570140000004)
[(2R,3R,4R,5R,6S)-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate
C6H14NO8P (259.04570140000004)
3-Amino-3-deoxy-beta-D-fructofuranose 6-phosphoric acid
C6H14NO8P (259.04570140000004)
(5-Methylsulfanylpentanethioylamino) hydrogen sulfate
1-Methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide
3-(methylthio)-5-[4-(trifluoromethyl)phenyl]-1H-1,2,4-triazole
(2r)-2-Azanyl-3-[(1r,2s)-2-Oxidanyl-1-Phosphono-Propyl]sulfanyl-Propanoic Acid
2-azaniumyl-2-deoxy-1-O-(hydroxyphosphinato)-alpha-D-galactopyranose
C6H14NO8P (259.04570140000004)
1-Amino-1-deoxy-scyllo-inositol 4-phosphate
C6H14NO8P (259.04570140000004)
O(4)-phosphonato-D-tyrosine(2-)
C9H10NO6P (259.02457300000003)
An optically active form of O(4)-phosphonatotyrosine(2-) having D-configuration.
(5-Amino-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate
C6H14NO8P (259.04570140000004)
2-amino-2-deoxy-D-glucopyranose 6-phosphate
C6H14NO8P (259.04570140000004)
The pyranose form of D-glucosamine 6-phosphate.
aldehydo-D-glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
alpha-D-glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
A 2-amino-2-deoxy-D-glucopyranose 6-phosphate that has an alpha-configuration at the anomeric position.
glycerol 1-phosphoserine
C6H14NO8P (259.04570140000004)
A L-serine derivative consisting of L-serine having a 1-glycerophospho group attached to the side-chain hydroxy function.
O(4)-phosphonato-L-tyrosine(2-)
C9H10NO6P (259.02457300000003)
An optically active form of O(4)-phosphonatotyrosine(2-) having L-configuration.
(2E)-4-hydroxy-3-methylbut-2-enyl diphosphate(3-)
An organophosphate oxoanion that is the trianion of (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate arising from deprotonation of the three OH groups of the diphosphate.
(5-amino-3,4,6-trihydroxyoxan-2-yl)methoxyphosphonic acid
C6H14NO8P (259.04570140000004)